JP2010100606A - Lotion - Google Patents

Lotion Download PDF

Info

Publication number
JP2010100606A
JP2010100606A JP2009079766A JP2009079766A JP2010100606A JP 2010100606 A JP2010100606 A JP 2010100606A JP 2009079766 A JP2009079766 A JP 2009079766A JP 2009079766 A JP2009079766 A JP 2009079766A JP 2010100606 A JP2010100606 A JP 2010100606A
Authority
JP
Japan
Prior art keywords
group
lotion
wound
burns
electrolyzed water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009079766A
Other languages
Japanese (ja)
Other versions
JP5582711B2 (en
Inventor
Masahiro Okajima
眞裕 岡島
Fumiyoshi Ishii
文由 石井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AI SYSTEM PRODUCT KK
Original Assignee
AI SYSTEM PRODUCT KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AI SYSTEM PRODUCT KK filed Critical AI SYSTEM PRODUCT KK
Priority to JP2009079766A priority Critical patent/JP5582711B2/en
Publication of JP2010100606A publication Critical patent/JP2010100606A/en
Application granted granted Critical
Publication of JP5582711B2 publication Critical patent/JP5582711B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

<P>PROBLEM TO BE SOLVED: To provide a lotion utilizing electrolytically reduced water based on the finding that electrolytically reduced water is effective for curing burns. <P>SOLUTION: A lotion using electrolytically reduced water is prepared. The curing effect of the lotion for burns is studied. Third degree burns are caused on the skin of the back of mice. The electrolyzed water lotion is applied on the burns region (once a day) immediately after the burns are caused. When comparison is made between the group applied with the electrolyzed water lotion ((+) group) and the group applied with a physiological saline lotion ((-) group) as a control group on the burns region, a significant reduction in the injured area is observed in the (+) group. Further, histologic findings are that tissue spaces, blood vessels and lymphatic vessels are much observed in the subcutaneous tissue of the (-) group, whereas little in the subcutaneous tissue of the (+) group. The results above shows the electrolyzed water lotion is effective for curing burns region over the control and indicates the electrolyzed water lotion may possibly promote to heal burns region. <P>COPYRIGHT: (C)2010,JPO&INPIT

Description

本発明は、電解還元水を含有する塗薬に関する。   The present invention relates to a coating agent containing electrolytic reduced water.

従来より、やけどやアトピーの治療には、化学薬品を含有する塗薬が用いられており、所定の成果をあげている。   Conventionally, coatings containing chemicals have been used for the treatment of burns and atopy and have achieved predetermined results.

しかし、化学薬品を含有する塗薬は、人によって向き不向きがあり、治療方法を間違うと症状が悪化する症例も数多く見られる。
そこで本発明では、万人に害がなく、しかも、やけどやアトピーの治療薬としても優れた効能を発揮する塗薬を提供することを目的とする。
However, there are many cases in which symptoms containing chemicals are unsuitable for some people and the symptoms worsen if the treatment method is wrong.
Therefore, an object of the present invention is to provide a coating agent that is harmless to all people and that exhibits excellent efficacy as a therapeutic agent for burns and atopy.

上記目的を達成するためになされた発明である請求項1に記載の塗薬は、PH(水素イオン濃度指数)10.5〜PH14の電解還元水を含有することを特徴とする。
この塗薬は、PH値が高いだけで、電気分解により還元した自然水である。しかも、この塗薬は、実験により、やけどやアトピーの患部に塗って治療を行うと優れた改善効果を発揮した。
The coating composition according to claim 1, which is an invention made to achieve the above object, is characterized by containing electrolytic reduced water having a pH (hydrogen ion concentration index) of 10.5 to PH14.
This coating is natural water that has only a high PH value and is reduced by electrolysis. In addition, this coating agent showed an excellent improvement effect when it was applied to the affected area of burns and atopy by treatment.

従って、この請求項1に記載された塗薬は、自然水を用いているので万人に害がなく、しかも、やけどやアトピーの治療薬として優れた効能を発揮する塗薬として用いることができる。   Therefore, the coating agent described in claim 1 is harmless to all since natural water is used, and can be used as a coating agent that exhibits excellent efficacy as a treatment for burns and atopy. .

尚、電解還元水のPH値は、11.5〜12.5がより好ましく、12がもっとも好ましい。
ところで、一般に室温(15℃〜20℃)の自然水の表面張力は70dyn/cm以上であるが、この電解還元水としては、請求項2に記載したように、表面張力が70dyn/cm以下のものを用いることが好ましい。表面張力が小さいと、患部への電解還元水の浸透がスムーズに進み、患部の改善に効能があるからである。
The PH value of the electrolytically reduced water is more preferably 11.5 to 12.5, and most preferably 12.
By the way, the surface tension of natural water at room temperature (15 ° C. to 20 ° C.) is generally 70 dyn / cm or more, and as the electrolytic reduced water, the surface tension is 70 dyn / cm or less as described in claim 2. It is preferable to use one. This is because when the surface tension is small, the electrolytic reduced water penetrates smoothly into the affected area, and is effective in improving the affected area.

尚、電解還元水としては、請求項3に記載したように、表面張力が62dyn/cm以下(80℃以上の熱水の表面張力に相当)であることがより好ましく、請求項4に記載したように、表面張力が58dyn/cm以下であることが一層好ましい。   In addition, as electrolytic reduction water, as described in claim 3, it is more preferable that the surface tension is 62 dyn / cm or less (corresponding to the surface tension of hot water of 80 ° C. or more). Thus, the surface tension is more preferably 58 dyn / cm or less.

次に、請求項5に記載したように、本発明の塗薬としては、電解還元水を、ゲル化剤を用いてゲル化したものであることが好ましい。
しかし、電解還元水のPH値が下がっては効能が保てないので、上記電解還元水のPH値を安定的に保つことができるゲル化剤としては、請求項6に挙げるものを用いることが好ましい。具体的には、ゲル化剤としては、ポリアクリレート類、セルロース類、天然ポリマー類のゲル化剤、あるいは、食品用増粘安定剤、化粧品用増粘剤として用いられるゲル化剤を用いることが好ましい。
Next, as described in claim 5, the coating agent of the present invention is preferably one obtained by gelling electrolytically reduced water using a gelling agent.
However, since the efficacy cannot be maintained if the PH value of the electrolytically reduced water is lowered, the gelling agent described in claim 6 can be used as a gelling agent capable of stably maintaining the PH value of the electrolytically reduced water. preferable. Specifically, as the gelling agent, it is possible to use a gelling agent for polyacrylates, celluloses, natural polymers, or a gelling agent used as a thickener for foods or a thickener for cosmetics. preferable.

また、電解還元水のPH値を安定的に保つことができるゲル化剤としては、実験により、請求項7に記載したカルボキシメチルセルロースナトリウムを用いることが最適であることが見出されたので、本発明の塗薬としては、カルボキシメチルセルロースをゲル化剤として用いることが好ましい。   In addition, as a gelling agent capable of stably maintaining the pH value of electrolytically reduced water, it has been found by experiment that it is optimal to use sodium carboxymethylcellulose described in claim 7. As the coating agent of the invention, it is preferable to use carboxymethyl cellulose as a gelling agent.

熱傷創作成直後の写真(A)と計測部位を描出したもの(B)、熱傷創後日数−創傷面積率のグラフ(C)である。It is a graph (C) of a photograph (A) immediately after burn wound creation, a drawing of the measurement site (B), and a number of days after burn wound-wound area ratio. 本実施形態のローションを塗布した創傷部分の写真と(+)、比較例の生理食塩水を塗布した創傷部分の写真(−)で、それぞれ傷を負った日から0,3,6,8,11日目の写真を示している。In the photograph of the wound part to which the lotion of the present embodiment was applied and (+), the photograph of the wound part to which the physiological saline solution of the comparative example was applied (−), 0, 3, 6, 8, The photograph of the 11th day is shown. 本実施形態のローションを塗布した創傷から3日後の創傷部分の写真と(+)、比較例の生理食塩水を塗布した創傷から3日後の創傷部分の写真(−)で、それぞれ創傷部分の断面の写真である。 図3Aは創傷部分の2倍の拡大写真で、図3A1は、図3A中の四角で囲った部分の10倍拡大写真で、図3A2は図3Aの20倍拡大写真で、図3A3は図3Aの30倍拡大写真である。 図3Bは創傷部分の2倍の拡大写真で、図3B1は、図3B中の四角で囲った部分の10倍拡大写真で、図3B2は図3Bの20倍拡大写真で、図3B3は図3Bの30倍拡大写真である。 図3A4及び図3B4は、それぞれの創傷直下の皮膚の厚さを示す写真である。The photograph of the wound part 3 days after the wound to which the lotion of this embodiment was applied and (+), and the photograph of the wound part 3 days after the wound to which the physiological saline solution of the comparative example was applied (-), respectively, It is a photograph of. 3A is a magnified photograph of 2 times the wound part, FIG. 3A1 is a magnified photograph of 10 times of the part surrounded by a square in FIG. 3A, FIG. 3A2 is a magnified photograph of 20 times of FIG. 3A, and FIG. It is a 30 times enlarged photograph. 3B is a magnified photograph of the wound part twice, FIG. 3B1 is a magnified photograph of 10 times of the part surrounded by the square in FIG. 3B, FIG. 3B2 is a magnified photograph of 20 times of FIG. 3B, and FIG. It is a 30 times enlarged photograph. 3A4 and 3B4 are photographs showing the thickness of the skin directly under each wound. 創傷から3日目の損傷付近の血管の拡大写真である。It is an enlarged photograph of the blood vessel near the injury on the third day from the wound.

以下、本発明が適用された実施形態について図面を用いて説明する。
[ 1.電解還元水を用いたローションの治癒効果についての概要 ]
電解還元水(以下、電解水)を含有するローション(本発明の塗薬に相当する)を調製し、そのローションにおける熱傷創の治癒効果を検討した。まず、マウス背部皮膚にIII度熱傷創を作成し、創傷直後より電解水ローションおよび対照として生理食塩水(以下、生食)を含んだローションを熱傷創部位にそれぞれ塗布(1日1回)した。そして、その創傷面積を経時的に計測し、さらに熱傷創部位(3日目)の組織学的検討を行った。熱傷創部位に関して、電解水ローションを塗布した群((+)群)および生食ローションを塗布した群((−)群)を比較すると、(+)群において創傷面積の縮小が有意に認められた。さらに、組織学的所見として、(−)群の皮下組織には組織間隙や血管・リンパ管が多く確認できたのに対して、(+)群では少なかった。以上の結果から、電解水ローションは対照と比較して熱傷創部位の治癒に有効性が認められ、熱傷創の治癒を促進する可能性が示唆された。
Embodiments to which the present invention is applied will be described below with reference to the drawings.
[1. Overview of healing effect of lotion using electrolytically reduced water]
A lotion (corresponding to the coating agent of the present invention) containing electrolytically reduced water (hereinafter, electrolyzed water) was prepared, and the healing effect of burn wounds in the lotion was examined. First, a third degree burn wound was created on the back skin of the mouse, and immediately after the wound, an electrolyzed water lotion and a lotion containing physiological saline (hereinafter, saline) as a control were applied to the burn wound site (once a day). Then, the wound area was measured over time, and histological examination of the burn wound site (day 3) was performed. When comparing the wound wound site with the group to which the electrolyzed water lotion was applied ((+) group) and the group to which the saline lotion was applied ((−) group), the wound area was significantly reduced in the (+) group. . Furthermore, as histological findings, many tissue gaps and blood vessels / lymph vessels were confirmed in the subcutaneous tissue of the (−) group, but there were few in the (+) group. From the above results, the electrolyzed water lotion was found to be more effective in healing the wound wound site than the control, suggesting the possibility of promoting the healing of the burn wound.

[ 2.創傷治療について ]
創傷治癒とは、外傷などで損傷を受けた組織が破壊され、欠損した組織や細胞に対し再生あるいは修復反応が起こる現象のことをいう。外傷には切創、挫創、刺創、熱傷および化学損傷などが含まれる。このような機転で喪失した組織自体と機能を生体が自主的に回復・再構築しようとする一連の生体反応を創傷治癒と呼ばれている。
[2. About wound treatment]
Wound healing refers to a phenomenon in which a tissue damaged by trauma or the like is destroyed, and a regeneration or repair reaction occurs on the lost tissue or cell. Injuries include cuts, wounds, stab wounds, burns and chemical damage. A series of biological reactions in which a living body tries to recover and reconstruct the tissue itself and functions lost by such a mechanism are called wound healing.

その中でも熱傷は熱によって皮膚が損傷された状態で、その程度により大きく3つに分類される。I度熱傷は皮膚表面の損傷、II度熱傷は真皮までの損傷で浮腫を伴う。III度熱傷は真皮、さらに皮下組織までに及ぶ損傷で、治癒後は瘢痕が残ることが多い。IIおよびIII度熱傷の治療は、従来までは創面の感染を抑えるために局所療法剤(イソジンなどの消毒薬、ステロイド含有軟膏剤、抗生剤含有軟膏剤など)を使用する治療法が主に行われてきたが、生体のもつ修復作用を最大限に利用しようという各種創傷被覆材(ポリウレタンフィルム、ハイドロコロイド、ポリウレタンフォームおよびハイドロジェルなどのドレッシング材、アルギン酸塩被覆材、ハイドロポリマーなど)を用いた密封療法へと変化してきた。   Among them, burns are a state in which the skin is damaged by heat, and is roughly classified into three according to the degree. Level I burns are skin surface damage, Level II burns are damage to the dermis and are accompanied by edema. A third-degree burn is an injury that extends to the dermis and even to the subcutaneous tissue, and scars often remain after healing. In the past, treatment of II and III burns has mainly been performed using topical therapies (such as disinfectants such as isodine, steroid-containing ointments, antibiotic-containing ointments, etc.) to suppress wound infection. We have been using various wound dressings (polyurethane films, hydrocolloids, polyurethane foams and hydrogel dressings, alginate dressings, hydropolymers, etc.) to make the most of the healing action of living bodies. It has changed to therapy.

これらの局所療法剤や創傷被覆材は損傷を受けた局所において、上皮形成の促進、感染予防、疼痛軽減などの重要な役割を果たしている。最近では塩基性線維芽細胞増殖因子(bFGF)製剤なども臨床応用され、熱傷創治癒の期間短縮に効果を発揮している。   These topical therapeutic agents and wound dressings play important roles in the damaged area, such as promoting epithelialization, preventing infection, and reducing pain. Recently, basic fibroblast growth factor (bFGF) preparations have been clinically applied and are effective in shortening the wound healing period.

[ 3.電解還元水について ]
本実施形態で用いる特殊電解還元性水(以下、電解水と略す:本発明の電解還元水に相当)は、自然水を電気分解で処理し、通電・加圧させて得られた物理的に電子過剰な水であり、特殊なアルカリ性質とマイナスイオンにより、匂いの元となる汚れや細菌の剥離作用によって除去するため、洗浄効果や消臭効果、除菌効果や防塵効果を示すことが知られている(商品名S−100:株式会社エー・アイ・システムプロダクト製造)。また、酸化を防止するため防錆および防腐効果も有している。さらに、乳化剤を添加せずに電解水のみによる乳化作用を示すことも見いだされた。これらの性質を利用して、現在は各種工業製品の洗浄液として広く用いられている。
[3. About electrolytically reduced water]
The special electrolytic reducing water used in the present embodiment (hereinafter abbreviated as electrolytic water: corresponding to the electrolytic reduced water of the present invention) is physically obtained by treating natural water by electrolysis, energizing and pressurizing. It is an electron-excess water, and it is known to show cleaning, deodorizing, sterilizing and dust-proofing effects because it is removed by the action of exfoliating dirt and bacteria that cause odors due to special alkaline properties and negative ions. (Trade name S-100: manufactured by AI System Product Co., Ltd.). It also has rust and antiseptic effects to prevent oxidation. Furthermore, it has also been found that an emulsifying action by electrolyzed water alone is shown without adding an emulsifier. Utilizing these properties, they are now widely used as cleaning solutions for various industrial products.

本実施形態で用いる電解水は、具体的には、脱酸素処理を行って純水の溶存酸素を1ppm以下にする脱酸素工程と、この脱酸素工程により脱酸素処理を行った前記純水に微量の食塩等の電解質を入れた水を電気分解する電気分解工程と、この電気分解工程により電気分解された前記水のうち、陰極室側の前記水を密閉された安定化槽内で4kg/cm2 以上の圧力をかけて安定化させる安定化工程とを経て、前記水を処理することによって製造する。   Specifically, the electrolyzed water used in the present embodiment is a deoxygenation process in which deoxygenation treatment is performed to reduce dissolved oxygen in pure water to 1 ppm or less, and the pure water that has undergone deoxygenation treatment in this deoxygenation process. An electrolysis process for electrolyzing water containing an electrolyte such as a small amount of sodium chloride, and among the water electrolyzed by this electrolysis process, the water on the cathode chamber side is 4 kg / kg in a sealed stabilization tank. It is manufactured by treating the water through a stabilization step of stabilizing by applying a pressure of cm 2 or more.

化学的な性質としては、本実施形態で用いる電解水は、PH12で安定している。
この電解水の水素イオン濃度指数は、PH12に限らず、PH10.5〜PH14で安定化していればよく、より好ましくはPH11.5〜PH12.5で安定していればよい。
As a chemical property, the electrolyzed water used in this embodiment is stable at PH12.
The hydrogen ion concentration index of the electrolyzed water is not limited to PH12, but may be stabilized at PH10.5 to PH14, and more preferably at PH11.5 to PH12.5.

また、他の化学的な性質としては、本実施形態で用いる電解水は、56.1dyn/cmの表面張力を有している(表面張力計:ドイツMax Planck Institute of Colloids and Interfaces社製 BPA -800Pモデル)。   As other chemical properties, the electrolyzed water used in the present embodiment has a surface tension of 56.1 dyn / cm (surface tension meter: BPA-manufactured by Max Planck Institute of Colloids and Interfaces, Germany) 800P model).

この電解水の表面張力は、室温における自然水の表面張力(70dyn/cm以上)よりも小さければ、患部に浸透する効能が見られるので、70dyn/cm以下であることが好ましく、62dyn/cm以下、さらに58dyn/cm以下であることがより好ましい。   If the surface tension of the electrolyzed water is smaller than the surface tension of natural water at room temperature (70 dyn / cm or more), the effect of penetrating into the affected area is seen. Therefore, the surface tension is preferably 70 dyn / cm or less, and 62 dyn / cm or less. Furthermore, it is more preferable that it is 58 dyn / cm or less.

尚、電解水の表面張力は29〜62dyn/cm範囲でもよいし、55〜58dyn/cmでもよいし、56.1dyn/cmであることがより好ましい。
本実施形態では、この電解水の医薬品への応用を検討するため、電解水を用いて熱傷創における治癒の促進効果を検討した。
The surface tension of the electrolyzed water may be in the range of 29 to 62 dyn / cm, 55 to 58 dyn / cm, and more preferably 56.1 dyn / cm.
In this embodiment, in order to examine the application of this electrolyzed water to pharmaceuticals, the effect of promoting healing in burn wounds was examined using electrolyzed water.

[ 4.検討方法 ]
<4.1.動物の取り扱いについて>
本検討では、7〜10週齢のddy雄性マウスを計20匹使用した。
[4. Study method]
<4.1. Handling animals>
In this study, a total of 20 ddy male mice aged 7 to 10 weeks were used.

<4.2.実験材料>
電解水は、株式会社エー・アイ・システムプロダクト社製の電解水S−100を用いた 。また、各種試薬はすべて特級品を使用した。
<4.2. Experimental Materials>
As the electrolyzed water, electrolyzed water S-100 manufactured by AI System Product Co., Ltd. was used. Moreover, all the various reagents used special grades.

<4.3.電解水および生食ローションの調製>
電解水および生食ローションは分散媒(電解水あるいは生食)に、撹拌下でゲル化剤であるカルボキシメチルセルロースナトリウム(関東化学株式会社)を添加し、最終濃度で7%になるようにそれぞれ調製した。
<4.3. Preparation of electrolyzed water and saline lotion>
Electrolyzed water and saline lotion were prepared in a dispersion medium (electrolyzed water or saline) by adding sodium carboxymethylcellulose (Kanto Chemical Co., Ltd.) as a gelling agent with stirring to a final concentration of 7%.

<4.4.熱傷創作成方法>
ペントバルビタールナトリウム(ナカライテスク株式会社)の腹腔内注射による麻酔下、橋本らおよび射場らの報告を参考にしてマウス背部を電気バリカンで刈り、さらに除毛クリームで除毛した。そして、背部に300℃に熱した電気ゴテ(白光株式会社製)のコテ先を5秒間当てることで、III度熱傷創を作成した。電気ゴテはコテ先の側面を均一にあて、創傷作成時の圧力が一定になるようにした。なお、実験の不均一性を極力避けるため創傷の作成は同一実験者が行った。
<4.4. Burn wound creation method>
Under anesthesia by intraperitoneal injection of sodium pentobarbital (Nacalai Tesque), the back of the mouse was shaved with an electric clipper with reference to the reports of Hashimoto et al. And the III degree burn wound was created by applying the iron tip of the electric iron (made by Hakumitsu Co., Ltd.) heated to 300 degreeC to the back part for 5 seconds. The electric iron was applied uniformly to the side of the iron tip so that the pressure at the time of wound creation was constant. In addition, in order to avoid the heterogeneity of the experiment as much as possible, the same experimenter created the wound.

<4.5.熱傷創面積の計測>
マウス14匹に対して熱傷創を作成した後、7匹ずつ2群に分けた。
そして、それぞれ電解水ローションを塗布した群((+)群)および生食ローションを塗布した群((−)群)とした。まず、創傷を作成した直後にデジタルカメラで創傷部位の撮影を行った(0日目)。創傷作成後、1日1回電解水および生食ローションを各群に塗布し、1,2,3,6,8,10,11,13,15日目に写真撮影を行った。そして、デジタルカメラで得られた画像データをソフトウェアImage J(株式会社バイオアーツ社)を使用して、創傷面積を計測した。創傷作成日の測定値を100%として、各測定日の創傷面積の比率(%)を求め、電解水ローションの治癒効果を検討した。
<4.5. Measurement of burn wound area>
After creating burn wounds for 14 mice, 7 mice were divided into 2 groups.
And it was set as the group ((+) group) which apply | coated the electrolysis water lotion, and the group ((-) group) which apply | coated the saline lotion, respectively. First, immediately after the wound was created, the wound site was photographed with a digital camera (Day 0). After wound preparation, electrolyzed water and saline lotion were applied to each group once a day, and photographs were taken on days 1, 2, 3, 6, 8, 10, 11, 13, and 15. And the wound area was measured for the image data obtained with the digital camera using software Image J (Bioarts Corporation). Taking the measurement value on the wound creation date as 100%, the ratio (%) of the wound area on each measurement day was determined, and the healing effect of the electrolyzed water lotion was examined.

<4.6.組織学的検討>
6匹のマウスの背部1カ所に電気ゴテをあて、同様に熱傷創を作成した。
3匹ずつの2群にわけ、1日1回電解水および生食ローションを各群に塗布した。創傷作成3日後、ジエチルエーテルの吸入麻酔下でサクリファイスし、創傷周辺の組織も含めた皮膚を摘出した。病理検査用20%中性緩衝ホルマリン溶液(関東化学株式会社)で浸漬固定後、4μmの厚さのパラフィン切片を作製し、へマトキシリン・エオジン染色(以下、HE染色)を施し皮膚断面の組織標本を作製した。その後、光学顕微鏡を用いて各標本を写真撮影し、組織観察をした。なお、組織標本の作製およびその評価は、株式会社組織科学研究所に依頼した。
<4.6. Histological examination>
A burn wound was created in the same manner by applying an electric iron to one back of six mice.
Divided into 2 groups of 3 animals, electrolytic water and saline lotion were applied to each group once a day. Three days after the creation of the wound, it was sacrified under inhalation anesthesia with diethyl ether, and the skin including the tissue around the wound was removed. After immersion and fixation with 20% neutral buffered formalin solution for pathological examination (Kanto Chemical Co., Inc.), 4 μm thick paraffin sections were prepared, and hematoxylin and eosin staining (hereinafter referred to as HE staining) was applied. Was made. Thereafter, each specimen was photographed using an optical microscope, and the tissue was observed. The preparation and evaluation of tissue specimens were commissioned to the Institute for Tissue Science.

<4.7.創傷付近の血管の観察>
組織学的評価で用いたマウス6匹について、熱傷創作成の3日後サクリファイスし、背部皮膚を摘出した後、皮下組織の毛細血管の状態を確認した。
<4.7. Observation of blood vessels near wound>
Six mice used in the histological evaluation were sacrified three days after the creation of the burn wound, and after removing the back skin, the state of the capillary in the subcutaneous tissue was confirmed.

<5.結果>
今回行った実験では、医薬品への応用を検討するため、電解水ローションを用いて熱傷創における治癒効果を検討した。創傷治癒を評価する一般的な指標としては、別の上皮化が完了するまでの日数や創傷面積が用いられている。
<5. Result>
In this experiment, we examined the healing effect on burn wounds using electrolyzed water lotion to examine its application to pharmaceuticals. As a general index for evaluating wound healing, days until the completion of another epithelialization and wound area are used.

そこで、今回の実験では、マウス背部皮膚にIII度熱傷を作成後、創傷面積を経時的に計測し、対照として生食ローションを塗布したものと比較・検討した。
<5.1.創傷面積の時間的経過>
図1には、熱傷創作成直後の写真(A)と計測部位を描出したもの(B)を示した。図1Bにおいて、楕円で囲んだ箇所が電気ゴテの接触した部分で、創傷と判断した部位である。
Therefore, in this experiment, after creating a third degree burn on the dorsal skin of the mouse, the wound area was measured over time, and compared with a case where a saline lotion was applied as a control.
<5.1. Time course of wound area>
FIG. 1 shows a photograph (A) immediately after creation of a burn wound and a drawing (B) depicting a measurement site. In FIG. 1B, a portion surrounded by an ellipse is a portion that is in contact with the electric iron, and is a portion determined to be a wound.

図1Cには、熱傷創後日数−創傷面積率のグラフを示した。このグラフから、創傷作成日の創面積を100%として、各測定日の計測比率を比較すると、1日目を除いた計測時点において(+)群は(−)群より有意に小さいことが分かる。また、(−)群では受傷2日後まで創傷の縮小傾向は見られなかったが、(+)群は2日目から縮小傾向が認められた。   FIG. 1C shows a graph of the number of days after burn wound-wound area ratio. From this graph, when the wound area on the wound creation day is set to 100% and the measurement ratio of each measurement day is compared, it can be seen that the (+) group is significantly smaller than the (−) group at the time of measurement excluding the first day. . In the (−) group, no tendency to shrink the wound was observed until 2 days after the injury, but the (+) group showed a tendency to shrink from the second day.

<5.2.熱傷創作成後の治癒の推移>
図2の写真に示すように、熱傷創作成後、1日1回電解水および生食ローションを各群に塗布し、0,3,6,8,11日目に写真撮影を行った。そして、(+)群および(−)群の創傷部位を比較した。
<5.2. Transition of healing after burn wound creation>
As shown in the photograph of FIG. 2, after creating the burn wound, electrolytic water and saline lotion were applied to each group once a day, and photographs were taken on the 0th, 3rd, 6th, 8th, and 11th days. And the wound site | part of the (+) group and the (-) group was compared.

その結果、6日目より(−)群と比較して明らかに(+)群の治癒効果が認められた。さらに、11日目では(+)群がほぼ完治の状態になった。
<5.3.熱傷作成3日後の皮膚組織画像>
1)熱傷創周囲の鏡検
熱傷創処理3日後のHE染色(ヘマトキシリン・エオシン染色)した創傷部位断面の全体像(2倍)を示した(図3AB)。図3A及び図3A1〜A3は、(+)群の写真で、電解水ローションを塗布したものである。図3B及び図3B1〜B3は、(−)群の写真で、生食ローションを塗布したものである。比較例として、図3C1〜C2は、「正常部位」の写真で、表皮や付属器に異常の見られない部位を示している。また、写真中に示した矢頭印は創傷部位の中心を表し、Epiは表皮、Derは真皮、SCは皮下組織、CMは皮筋をそれぞれ示す。
As a result, the healing effect of the (+) group was clearly recognized as compared with the (−) group from the 6th day. Furthermore, on the 11th day, the (+) group was almost completely cured.
<5.3. Skin tissue image 3 days after burn creation>
1) Microscopic examination around the burn wound The whole image (2 times) of the wound site cross section after HE burn (hematoxylin and eosin stain) 3 days after the burn wound treatment was shown (FIG. 3AB). FIG. 3A and FIGS. 3A1 to A3 are photographs of the (+) group in which electrolytic water lotion is applied. FIG. 3B and FIGS. 3B1 to B3 are photographs of the (−) group, in which a saline lotion is applied. As a comparative example, FIGS. 3C1 to C2 are photographs of “normal sites”, showing sites where no abnormality is seen in the epidermis or appendages. Moreover, the arrowhead mark shown in the photograph represents the center of the wound site, Epi represents the epidermis, Der represents the dermis, SC represents the subcutaneous tissue, and CM represents the skin muscle.

(+)群に関して、図3A中の□で示した部分(創傷部位の左側辺縁部)を拡大(10倍)したものがA1、さらに、A1の創傷部位の表皮側拡大像(20倍)がA2およびA1の創傷部位の皮下組織側拡大像(20倍)がA3である。   Regarding the (+) group, an enlarged (10 times) portion indicated by □ in FIG. 3A (left side edge of the wound site) is A1, and further, an enlarged image of the epidermis side of the wound site of A1 (20 times) A3 is an enlarged image (20 times) of the subcutaneous tissue side of the wound sites A2 and A1.

同様にして、対照となる(−)群に関して、図3B中の□で示した部分(創傷部位の左側辺縁部)を拡大(10倍)したものがB1、さらに、B1の創傷部位の表皮側拡大像(20倍)がB2およびA1の創傷部位の皮下組織側拡大像(20倍)がB3である。   Similarly, with respect to the control (-) group, an enlarged (10 times) portion indicated by □ in FIG. 3B (left side edge of the wound site) is B1, and further, the epidermis of the wound site of B1 The side magnified image (20 times) is B2 and the subcutaneous tissue side magnified image (20 times) of the wound site of A1 is B3.

また、正常皮膚組織部位を拡大(10倍)したものがC1、さらに、C1の創傷部位の表皮側拡大像(20倍)がC2およびC1の創傷部位の皮下組織側拡大像(20倍)がC3である。   Further, an enlarged (10 times) normal skin tissue site is C1, and further, an epidermis side enlarged image (20 times) of the wound site of C1 is a subcutaneous tissue side enlarged image (20 times) of the wound sites of C2 and C1. C3.

(−)群の創傷部位の皮下組織(SC)は、HE染色に染まらない部分が多く見られた(図3B1)。これは組織間隙や血管およびリンパ管が多いことを示しており、(+)群では染色性が密であることから(−)群と比較して創傷が軽微であることを示唆している(図3A1)。   In the subcutaneous tissue (SC) of the wound site of the (−) group, many portions not stained with HE staining were observed (FIG. 3B1). This indicates that there are many tissue gaps, blood vessels and lymphatic vessels, and the staining is dense in the (+) group, suggesting that the wound is minor compared to the (−) group ( FIG. 3A1).

2)熱傷創直下の鏡検
創傷直下の皮膚の厚さを正常皮膚と比較したところ、(−)群は表皮および真皮に変形が見られるものの、(+)群と同様に有意な差は認められなかった(図3A4、B4)。また、(+)および(−)の創傷直下では、HE染色で青紫色に染色された炎症性細胞(主に好中球)がより多く浸潤していることが観察された。
2) Microscopic examination directly under the wound wound When comparing the thickness of the skin directly under the wound with that of normal skin, the (-) group showed deformation in the epidermis and dermis, but no significant difference was observed as in the (+) group. (FIG. 3A4, B4). In addition, it was observed that inflammatory cells (mainly neutrophils) stained blue-purple with HE staining were more infiltrated just below the (+) and (−) wounds.

<5.4.熱傷作成3日後の皮下組織の血管>
皮下組織側から創傷付近の血管について確認した。図4は、その損傷付近の血管の拡大写真である。図4に示すように、熱傷創およびその周辺の部位において、(−)群は(+)群と比較し、血管が確認できた。
<5.4. Blood vessel in subcutaneous tissue 3 days after burn creation>
The blood vessels near the wound were confirmed from the subcutaneous tissue side. FIG. 4 is an enlarged photograph of a blood vessel near the damage. As shown in FIG. 4, blood vessels were confirmed in the burn wound and the surrounding area as compared with the (+) group in the (−) group.

[ 4.考察 ]
電解水の熱傷創治癒を確認するため、電解水の創面への塗布効果を検討した。当初、電解水をそのまま塗布したが、すぐに乾いてしまい、湿潤環境が維持できなかった。そこで、創面の湿潤環境を維持するために軟膏剤の調製や被覆材などの使用も検討したが、創面の経時的変化を観察しやすくするため、透明で粘度があり、それ自体には薬理作用がないカルボキシメチルセルロースナトリウム(以下、CMC-Naと略す)を用いて、ローションの剤形にした。このCMC-Naは、被覆材にも用いられている製剤用高分子で、水に容易に溶け、粘性、安定性、保護コロイド性などの特性を持っていることから、分散剤や結合剤として多く用いられている。実験に際して、粘性のあるローションの剤形にすることで、熱傷創部位に長時間電解水を留め、その治癒の持続効果を図った。
[4. Discussion]
In order to confirm the wound healing of electrolyzed water, the effect of applying electrolyzed water on the wound surface was examined. Initially, electrolyzed water was applied as it was, but it dried quickly and the moist environment could not be maintained. In order to maintain the moist environment of the wound surface, preparation of an ointment and the use of a covering material were also examined, but in order to make it easier to observe changes over time of the wound surface, it is transparent and viscous, and itself has a pharmacological action. A lotion dosage form was prepared using sodium carboxymethylcellulose (hereinafter abbreviated as CMC-Na). This CMC-Na is a pharmaceutical polymer that is also used as a coating material. It is easily dissolved in water and has properties such as viscosity, stability and protective colloid properties. Many are used. During the experiment, the dosage form of a viscous lotion was used to keep the electrolyzed water at the burn wound site for a long time, thereby maintaining the healing effect.

受傷後、1日1回電解水および生食ローションをそれぞれ塗布し、熱傷創モデルのマウス皮膚を受傷3日後に摘出した。そして、電解水の効果を病理組織学的に検査するため、HE染色標本を作製して鏡検観察した。電解水および生食ローションを塗布した検体において、組織学的にIII度の熱傷が観察された。そして、両者の組織所見を比較したところ明らかな差異が認められた(図3)。   After the injury, electrolyzed water and saline lotion were applied once a day, respectively, and the mouse skin of the burn wound model was removed 3 days after the injury. Then, in order to examine the effect of electrolyzed water histopathologically, HE-stained specimens were prepared and microscopically observed. In specimens applied with electrolyzed water and saline lotion, histologically third degree burns were observed. And when the tissue findings of both were compared, a clear difference was recognized (FIG. 3).

まず、対照である生食ローションを塗布した検体(−)の組織所見については、熱傷創部分の表皮は消失し、真皮全域が残存する付属器を含めて凝固壊死から融解壊死の状態に陥っていた(図3B1〜4)。さらに、壊死は皮筋まで及んでおり、特に熱傷創中央部分では筋線維の融解が激しかった。いわゆる「潰瘍」で、潰瘍部分は壊死組織と滲出物(痂皮)で埋まっている状態であった(図3B4)。真皮壊死部には多量の核崩壊産物(ヘマトキシリン陽性)が散見された。そして、潰瘍底にあたる皮下組織には著明な炎症性反応が認められた。また、熱傷創周囲の表皮は肥厚し、境界部には表皮の再生像(新生表皮が欠損部へ送り出されている像)が観察された。このあたりの真皮から皮下組織の炎症性細胞浸潤は著明で、皮筋の筋線経は萎縮していた。   First, regarding the histological findings of the specimen (-) applied with the raw saline lotion as a control, the epidermis of the burn wound part disappeared, and the entire dermis was in a state of coagulation necrosis to melting necrosis including the appendages. (FIG. 3B1-4). Furthermore, necrosis extended to the cutaneous muscle, and muscle fibers were severely melted, particularly in the central part of the burn wound. In the so-called “ulcer”, the ulcer portion was filled with necrotic tissue and exudate (scab) (FIG. 3B4). A large amount of nuclear decay products (positive for hematoxylin) were found in the dermal necrotic area. A marked inflammatory reaction was observed in the subcutaneous tissue at the bottom of the ulcer. In addition, the epidermis around the burn wound was thickened, and a reconstructed image of the epidermis (image where the new epidermis was sent to the defect) was observed at the boundary. In this area, inflammatory cell infiltration from the dermis to the subcutaneous tissue was remarkable, and the muscle line of the cutaneous muscle was atrophied.

一方、電解水ローションを塗布した検体の組織所見については、熱傷創部分の表皮から真皮全域に凝固壊死に陥っているが、(−)群とは異なり、表皮や付属器の構造が残存していた(図3A1−4)。更に、凝固壊死は皮筋まで及んでいるが、(−)群よりも軽微で、融解壊死に陥らず筋線経の構造が保たれていた。熱傷創中央の皮下組織には著明な炎症性反応や肉芽組織の増生が認められた(図3A4)。また、創傷周囲の表皮は肥厚し、境界部には表皮の再生像が観察されたが、その新生表皮が欠損部へ送りだされている量は(−)群よりも少ない。このあたりの真皮から皮下組織の炎症性細胞浸潤は軽微で、皮筋の筋線維は萎縮していた。   On the other hand, regarding the tissue findings of the specimens to which the electrolyzed water lotion was applied, coagulative necrosis occurred from the epidermis of the burn wound area to the entire dermis, but unlike the (−) group, the structure of the epidermis and appendages remained. (FIG. 3A1-4). Furthermore, although coagulative necrosis extends to the cutaneous muscle, it was less severe than the (−) group, and the structure of the myoline was maintained without falling into melting necrosis. A marked inflammatory reaction and an increase in granulation tissue were observed in the subcutaneous tissue at the center of the burn wound (FIG. 3A4). In addition, the epidermis around the wound was thickened, and a regenerated image of the epidermis was observed at the boundary portion, but the amount of the new epidermis fed to the defect portion was smaller than that in the (−) group. The inflammatory cell infiltration from the dermis to the subcutaneous tissue was slight, and the muscle fibers of the cutaneous muscle were atrophied.

次に、皮下組織側から創傷付近の血管について確認した(図4)。受傷3日目において、(−)群は毛細血管が受傷部およびその周辺で確認できたが、(+)群はほとんど認められなかった。これは図1Cの受傷3日目の段階で、(+)群が(−)群より創傷面積が明らかに小さい傾向にあり、このことも考慮すると、受傷3日目において(+)群が早期の段階で炎症期から肉芽形成期へスムーズに移行した可能性が考えられた。   Next, blood vessels near the wound were confirmed from the subcutaneous tissue side (FIG. 4). On the third day of the injury, in the (−) group, capillaries could be confirmed at and around the damaged portion, but the (+) group was hardly observed. This is the stage of the third day of injury in FIG. 1C, and the (+) group tends to have a smaller wound area than the (−) group, and considering this, the (+) group is earlier in the third day of the injury. The possibility of a smooth transition from the inflammatory stage to the granulation stage was considered.

以上、マウス皮膚熱傷創モデルにおける治療薬塗布の効果を病理組織学的に検討したところ、当初の熱傷創の程度が同等という前提において、創傷への電解水ローションによって受傷3日後までに生じる壊死性変化や炎症性反応を軽減する効果があることが示唆された。   As described above, when the effect of the therapeutic agent application on the mouse skin burn model was examined histopathologically, necrosis caused by electrolysis water lotion on wounds up to 3 days after injury was assumed on the premise that the degree of initial burn wound was equivalent. It was suggested that it has the effect of reducing changes and inflammatory reactions.

一般的に創傷治癒の行程は、炎症期、肉芽形成期、再構築期の3段階に分けることができる。今回の受傷3日後は炎症期に当たり、好中球などの細胞が損傷した細胞の貧食やサイトカインなどの生理活性物質を分泌していると思われた。   Generally, the process of wound healing can be divided into three stages: an inflammatory stage, a granulation stage, and a remodeling stage. Three days after this injury, the inflammatory phase was intensified, and it was thought that cells such as neutrophils secreted phagocytosed cells and physiologically active substances such as cytokines.

今回の実験結果から、(+)群は真皮から皮下組織の炎症性細胞浸潤は(−)群と比較して少なかったことから、電解水は炎症過程を少なく留める性質があるのかもしれない(図3A1、B1)。   From the results of this experiment, the (+) group had less inflammatory cell infiltration from the dermis to the subcutaneous tissue compared to the (−) group, so electrolyzed water may have the property of keeping the inflammation process small ( FIG. 3A1, B1).

今回、電解水ローションの熱傷創への効果を検討した結果、創傷治癒の促進効果が示唆された。
[ 5.結論 ]
III度熱傷創に対する電解水ローションの創傷治癒効果を実験的に検討した。その結果、電解水ローションは熱傷創の改善に有効であり、熱傷創治癒を促進する可能性が示唆された。
As a result of examining the effect of electrolysis water lotion on burn wounds, it was suggested that wound healing was promoted.
[5. Conclusion]
The wound healing effect of electrolyzed water lotion on the third degree burn wound was examined experimentally. As a result, it was suggested that electrolyzed water lotion is effective in improving burn wounds and may promote burn wound healing.

[ 6.その他 ]
〈6.1〉
上記実験では、やけどの効能についてのみ示しているが、他の実験において、アトピー性疾患の患部に、本実施形態の電解水ローションを塗布したところ、2週間程度で、患部が目立たない程度にまで改善される結果を見た。
[6. Others]
<6.1>
In the above experiment, only the efficacy of burns is shown, but in other experiments, when the electrolyzed water lotion of this embodiment was applied to the affected area of the atopic disease, the affected area was not noticeable in about 2 weeks. Saw improved results.

〈6.2〉
本実施形態の電解水ローションは殺菌作用を発揮することも見出されているが、口内から取り出した歯周菌に電解水ローションを垂らすと、99%の歯周菌が死滅した。
<6.2>
It has been found that the electrolyzed water lotion of the present embodiment exerts a bactericidal action, but when the electrolyzed water lotion is hung on the periodontal bacteria taken out from the mouth, 99% of the periodontal bacteria are killed.

また、本実施形態の電解水ローションは、口内から歯周菌とともに取り出した酪酸に電解水ローションを数滴垂らすと酪酸を中和する作用があることが見出された。
酪酸は、歯茎を通して体内に侵入すると白血球の免疫細胞を破壊する機能を有するので、本実施形態の電解水ローションによって口内の酪酸を中和することで、体内の免疫細胞を保護することができる。その結果、体内の免疫細胞は体内でガン細胞やエイズウイルス等を破壊するので、本実施形態の電解水ローションを歯の治療薬や歯磨き剤として利用すると、歯槽膿漏や虫歯の治療及び予防になるだけでなく、ガンの治療及び予防、エイズの治療及び予防にもなる。
Moreover, it was found that the electrolyzed water lotion of this embodiment has an effect of neutralizing butyric acid when a few drops of electrolyzed water lotion are dripped onto butyric acid taken out from the mouth together with periodontal bacteria.
Butyric acid has a function of destroying leukocyte immune cells when it enters the body through the gums. By neutralizing butyric acid in the mouth with the electrolyzed water lotion of this embodiment, it is possible to protect the immune cells in the body. As a result, the immune cells in the body destroy cancer cells, AIDS virus, etc. in the body, so if the electrolyzed water lotion of this embodiment is used as a dental treatment or dentifrice, it will be used for the treatment and prevention of alveolar pyorrhea and dental caries. Not only does it become cancer treatment and prevention, it also treats and prevents AIDS.

〈6.3〉
また、上記実験とは別に行っている保存実験により、本実施形態の電解水ローションは1年以上を経過しても、PH値に変化がないため保存性能のあることがわかっている。つまり、ゲル化剤としては上述したカルボキシメチルセルロースナトリウムがもっとも好ましいという発見があった。
<6.3>
Moreover, it is known from a storage experiment conducted separately from the above experiment that the electrolyzed water lotion of the present embodiment has a storage performance because the PH value does not change even after one year or more. That is, it has been found that the above-mentioned sodium carboxymethyl cellulose is most preferable as the gelling agent.

ただし、カルボキシメチルセルロースナトリウムのような保存性能を求めないのであれば、ゲル化剤としては、ポリアクリレート類、セルロース類、天然ポリマー類のゲル化剤や、食品用増粘安定剤、化粧品用増粘剤として用いられるゲル化剤を用いてもよい。   However, if storage performance such as sodium carboxymethylcellulose is not required, gelling agents such as polyacrylates, celluloses, natural polymers, thickeners for foods, thickeners for cosmetics You may use the gelatinizer used as an agent.

ポリアクリレート類としては、ポリアクリレート、カルボキシビニルポリマーが好ましい。
セルロース類としては、カルボキシメチルセルロースナトリウム塩、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、メチルセルロース等が好ましい。
As polyacrylates, polyacrylates and carboxyvinyl polymers are preferred.
As the cellulose, carboxymethylcellulose sodium salt, hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, methylcellulose and the like are preferable.

天然ポリマー類としては、キサンタンガム、カラギーナンナトリウム塩、アルギン酸ナトリウム、ヒドロキシプロピルグアガム、アラビアガム、トラガカントガム、グアーヒドロキシプロピルトリモニウムクロリド、等が好ましい。   As natural polymers, xanthan gum, carrageenan sodium salt, sodium alginate, hydroxypropyl guar gum, gum arabic, tragacanth gum, guar hydroxypropyltrimonium chloride and the like are preferable.

食品用増粘安定剤としては、ペクチン、グアーガム、キサンタンガム、タマリンドガム、カラギーナン、プロピレングリコール、プロピレングリコール脂肪酸エステル、カルボキシメチルセルロースナトリウム(CMC)等が好ましい。   As the thickener for food, pectin, guar gum, xanthan gum, tamarind gum, carrageenan, propylene glycol, propylene glycol fatty acid ester, sodium carboxymethylcellulose (CMC) and the like are preferable.

化粧品用増粘剤としては、ペクチン、 アラビアガム、 アルギニン・カルボマー(カルボキシビニルポリマー)/カルボマー、アルギン酸ナトリウム/アルギン酸Na、 アルギン酸プロピレングリコール/アルギン酸PG、 エチルセルロース、 カルボキシメチルセルロースナトリウム/セルロースガム/グリコール酸ナトリウム/CMC、 キサンタンガム、 ジェランガム、 ヒドロキシプロピルグアーガム(HPグアー)、 ヒドロキシエチルセルロース(HEC)、 カチオン化グアーガム(グアーヒドロキシプロピルトリモニウムクロリド)、 ローカストビーンガム、 カチオン化セルロース(ポリクオタニウム-10)、 合成ケイ酸ナトリウム・マグネシウム、 ジメチルジステアリルアンモニウムヘクトライト/クオタニウム-18ヘクトライト、 シクロデキストリン/CD、 ポリアクリル酸ナトリウム/ポリアクリル酸Na、ラウラミドDEA、ジオレイン酸PEG-120メチルグルコース等が好ましい。   Cosmetic thickeners include pectin, gum arabic, arginine carbomer (carboxyvinyl polymer) / carbomer, sodium alginate / Na alginate, propylene glycol alginate / PG alginate, ethyl cellulose, sodium carboxymethyl cellulose / cellulose gum / sodium glycolate / CMC, xanthan gum, gellan gum, hydroxypropyl guar gum (HP guar), hydroxyethyl cellulose (HEC), cationized guar gum (guar hydroxypropyltrimonium chloride), locust bean gum, cationized cellulose (polyquaternium-10), synthetic sodium silicate Magnesium, dimethyl distearyl ammonium hectorite / quaternium-18 hectorite, B cyclodextrin / CD, sodium polyacrylate / polyacrylic acid Na, lauramide DEA, PEG-120 methyl glucose etc. dioleate preferred.

〈6.4〉
上記実施形態では、電解水ローションとしては、7%の濃度(重量比、電解水93:CMC−Na7)のものを用いたが、これに限られるものではない。用途に応じて、濃度を変えてもよいことはもちろんである。
<6.4>
In the above embodiment, the electrolyzed water lotion has a concentration of 7% (weight ratio, electrolyzed water 93: CMC-Na7), but is not limited thereto. Of course, the concentration may be changed according to the application.

本発明は、特許請求の範囲に記載された発明の趣旨に合致するものであればよく、上述の実施形態に限定されるものではない。   The present invention is not limited to the above-described embodiment as long as it matches the gist of the invention described in the claims.

Claims (7)

PH10.5〜PH14の電解還元水を含有することを特徴とする塗薬。 A coating agent comprising electrolytic reduced water having a pH of 10.5 to PH14. 請求項1に記載の塗薬において、
前記電解還元水は、
表面張力が70dyn/cm以下であることを特徴とする塗薬。
The coating composition according to claim 1,
The electrolytically reduced water is
A coating agent having a surface tension of 70 dyn / cm or less.
請求項2に記載の塗薬において、
前記電解還元水は、
表面張力が62dyn/cm以下であることを特徴とする塗薬。
In the coating agent according to claim 2,
The electrolytically reduced water is
A coating agent having a surface tension of 62 dyn / cm or less.
請求項3に記載の塗薬において、
前記電解還元水は、
表面張力が58dyn/cm以下であることを特徴とする塗薬。
In the coating agent according to claim 3,
The electrolytically reduced water is
A coating agent having a surface tension of 58 dyn / cm or less.
前記電解還元水を、ゲル化剤を用いてゲル化したことを特徴とする請求項1〜4のいずれかに記載の塗薬。   The coating agent according to any one of claims 1 to 4, wherein the electrolytically reduced water is gelled using a gelling agent. 請求項5に記載の塗薬において、
前記ゲル化剤は、
ポリアクリレート類、セルロース類、天然ポリマー類のゲル化剤、
あるいは、
食品用増粘安定剤、化粧品用増粘剤として用いられるゲル化剤
であることを特徴とする塗薬。
In the coating agent according to claim 5,
The gelling agent is
Gelling agents for polyacrylates, celluloses, natural polymers,
Or
A coating agent characterized by being a gelling agent used as a thickener for foods and a thickener for cosmetics.
前記ゲル化剤は、カルボキシメチルセルロースナトリウムであることを特徴とする請求項6に記載の塗薬。   The coating agent according to claim 6, wherein the gelling agent is sodium carboxymethylcellulose.
JP2009079766A 2008-09-25 2009-03-27 Lotion Active JP5582711B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009079766A JP5582711B2 (en) 2008-09-25 2009-03-27 Lotion

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2008245977 2008-09-25
JP2008245977 2008-09-25
JP2009079766A JP5582711B2 (en) 2008-09-25 2009-03-27 Lotion

Publications (2)

Publication Number Publication Date
JP2010100606A true JP2010100606A (en) 2010-05-06
JP5582711B2 JP5582711B2 (en) 2014-09-03

Family

ID=42291587

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009079766A Active JP5582711B2 (en) 2008-09-25 2009-03-27 Lotion

Country Status (1)

Country Link
JP (1) JP5582711B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022507794A (en) * 2018-11-21 2022-01-18 ウォーターディアム グループ エルエルシー Treatment of skin diseases with electrolyzed water
WO2022138923A1 (en) * 2020-12-25 2022-06-30 株式会社エー・アイ・システムプロダクト Ceramide synthesis promoter

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63500516A (en) * 1985-06-13 1988-02-25 トピカル システムズ リミテッド Composition
JPH069373A (en) * 1992-04-22 1994-01-18 Bristol Myers Squibb Co Hydrocolloid gel for wound
JPH07109220A (en) * 1993-03-23 1995-04-25 Johnson & Johnson Medical Inc Ointment for medical treatment of wound
JPH11512740A (en) * 1995-10-06 1999-11-02 エチコン・インコーポレーテツド Gel composition containing growth factor
JP2000247892A (en) * 1999-02-26 2000-09-12 Ikeda Bussan Kk Preparation composition
JP2002080374A (en) * 2000-09-05 2002-03-19 Hisamitsu Pharmaceut Co Inc Alkali ion water-containing medicine composition for mammal application
JP2002226373A (en) * 2001-01-31 2002-08-14 Mikasa Seiyaku Co Ltd Preparation for therapy of bedsore, cutaneous ulcer and wound
WO2004011032A1 (en) * 2002-07-26 2004-02-05 Mikasa Seiyaku Co., Ltd. External preparation
JP2007050400A (en) * 2005-07-20 2007-03-01 Ai System Product:Kk Method for producing minus ion water, and minus ion water

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63500516A (en) * 1985-06-13 1988-02-25 トピカル システムズ リミテッド Composition
JPH069373A (en) * 1992-04-22 1994-01-18 Bristol Myers Squibb Co Hydrocolloid gel for wound
JPH07109220A (en) * 1993-03-23 1995-04-25 Johnson & Johnson Medical Inc Ointment for medical treatment of wound
JPH11512740A (en) * 1995-10-06 1999-11-02 エチコン・インコーポレーテツド Gel composition containing growth factor
JP2000247892A (en) * 1999-02-26 2000-09-12 Ikeda Bussan Kk Preparation composition
JP2002080374A (en) * 2000-09-05 2002-03-19 Hisamitsu Pharmaceut Co Inc Alkali ion water-containing medicine composition for mammal application
JP2002226373A (en) * 2001-01-31 2002-08-14 Mikasa Seiyaku Co Ltd Preparation for therapy of bedsore, cutaneous ulcer and wound
WO2004011032A1 (en) * 2002-07-26 2004-02-05 Mikasa Seiyaku Co., Ltd. External preparation
JP2007050400A (en) * 2005-07-20 2007-03-01 Ai System Product:Kk Method for producing minus ion water, and minus ion water

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022507794A (en) * 2018-11-21 2022-01-18 ウォーターディアム グループ エルエルシー Treatment of skin diseases with electrolyzed water
WO2022138923A1 (en) * 2020-12-25 2022-06-30 株式会社エー・アイ・システムプロダクト Ceramide synthesis promoter
JPWO2022138923A1 (en) * 2020-12-25 2022-06-30

Also Published As

Publication number Publication date
JP5582711B2 (en) 2014-09-03

Similar Documents

Publication Publication Date Title
Alizadeh et al. Copper nanoparticles promote rapid wound healing in acute full thickness defect via acceleration of skin cell migration, proliferation, and neovascularization
Caravaggi et al. HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial
US8685944B2 (en) Viscoelastic gel for dermatological use
JP5657545B2 (en) Method for preparing an injectable hydrogel crosslinked in an injectable container
US20070231271A1 (en) Topical composition of biocellulose as gel, spray-aerosol, cream and/or aqueous for the treatment of epithelial lesions
Valachova et al. Skin wound healing with composite biomembranes loaded by tiopronin or captopril
WO2006109734A1 (en) External agent for treating wound
Hu et al. An All‐in‐One “4A Hydrogel”: through First‐Aid Hemostatic, Antibacterial, Antioxidant, and Angiogenic to Promoting Infected Wound Healing
Shi et al. Naturally derived dual dynamic crosslinked multifunctional hydrogel for diabetic wound healing
CN114903981A (en) Wound repair formula containing recombinant type III collagen
TW201737938A (en) Methods of debridement of chronic wounds
Vakilian et al. A Keratin-based biomaterial as a promising dresser for skin wound healing
DE60312969T2 (en) PREPARATION FOR WOUND HEALING AND PREVENTING THE POSSESSION OF ASSOCIATIONS TO THE WOUNDS
CN103785060B (en) Fish skin collagen support loading epidermal growth factors and preparation method thereof
JP5582711B2 (en) Lotion
RU2699362C2 (en) Composition based on cerium dioxide nanoparticles and brown algae polysaccharides for treating wounds
WO2020180202A1 (en) Composition based on cerium dioxide nanoparticles and brown algae polysaccharides for wound treatment
JPWO2016185811A1 (en) Coated contact media for ultrasonic diagnostics
Popova et al. Fabrication of CeO2 nanoparticles embedded in polysaccharide hydrogel and their application in skin wound healing
CN113041391A (en) Herba centellae-collagen-containing repairing freeze-dried sponge and preparation method thereof
Borghetti et al. Clinical and histologic evaluation of effects of hyaluronic acid in rat tongue
CN104225577B (en) A kind of double course for the treatment of compound cells growth factor hydrogels and preparation method and with application
Wang et al. Facile strategy for gelatin-based hydrogel with multifunctionalities to remodel wound microenvironment and accelerate healing of acute and diabetic wounds
CN114917403A (en) Mussel-like mucin gel as well as preparation method and application thereof
Fedota et al. Local treatment of burn wounds in animals using a new nanocomponent ointment

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120321

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130903

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130927

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140204

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140430

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20140508

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140624

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140715

R150 Certificate of patent or registration of utility model

Ref document number: 5582711

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250